Clinical Trial Update: Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating Anthocyanin Rich Extract (ACRE) in patients with Ulcerative Colitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Anthocyanin Rich Extract (ACRE)

Snippet

Sponsor: University of Zurich | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED